Editorial
doi: 10.1161/CIRCOUTCOMES.108.827329.
Anticoagulation control in atrial fibrillation: optimizing risks and benefits
- PMID: 20031792
- DOI: 10.1161/CIRCOUTCOMES.108.827329
Item in Clipboard
Editorial
Anticoagulation control in atrial fibrillation: optimizing risks and benefits
Circ Cardiovasc Qual Outcomes.
2008 Nov.
No abstract available
Comment on
-
Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.Circ Cardiovasc Qual Outcomes. 2008 Nov;1(2):84-91. doi: 10.1161/CIRCOUTCOMES.108.796185. Epub 2008 Nov 5. Circ Cardiovasc Qual Outcomes. 2008. PMID: 20031794
Similar articles
-
Stroke prevention in atrial fibrillation--pharmacologic strategies.Indian Heart J. 2007 Jul-Aug;59(4):311-5. Indian Heart J. 2007. PMID: 19126935 Review.
-
Atrial fibrillation and stroke prevention.Expert Rev Neurother. 2006 Oct;6(10):1523-30. doi: 10.1586/14737175.6.10.1523. Expert Rev Neurother. 2006. PMID: 17078791 Review.
-
Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin?Am Fam Physician. 2004 Sep 1;70(5):917-8. Am Fam Physician. 2004. PMID: 15368730 No abstract available.
-
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344. Thromb Haemost. 2008. PMID: 18612531 No abstract available.
-
Anticoagulation in the octogenarian with atrial fibrillation.Med Health R I. 2009 Apr;92(4):152-4. Med Health R I. 2009. PMID: 19452760
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
